Evidence map›Paper›PMID 20167089›Full record

ArticleBMC evolutionary biology2010

Functional evolution of the trace amine associated receptors in mammals and the loss of TAAR1 in dogs.

Eric J Vallender, Zhihua Xie, Susan V Westmoreland, Gregory M Miller

Open access · goldAbstract read
In one paragraph

Article in BMC evolutionary biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Eric J VallenderNew England Primate Research Center, Harvard Medical School, One Pine Hill Drive, Southborough, MA 01772, USA. eric_vallender@hms.harvard.edu
Zhihua Xie
Susan V Westmoreland
Gregory M Miller
New England Biolabs (United States) · USHarvard University · US

Funding

ZETA CHAIN OF T CELL RECEPTOR INTERACTS W/ NEF OF SIV &HIV2P51RR000168 · NCRR · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROWLETT, JAMES K · 1985 to 2011
$139.3M
Trace Amine Receptors in Non Human PrimatesR01DA016606 · NIDA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MILLER, GREGORY MICHAEL · 2004 to 2007
$1.2M
Drug Abuse-related Neurobiology and Genetic Variance Modeled in Rhesus MonkeysK02DA025697 · NIDA · HARVARD MEDICAL SCHOOL · PI MILLER, GREGORY MICHAEL · 2009 to 2013
$615k
Alcohol abuse pharmacogenomics: building naturalistic rhesus monkey modelsR21AA016194 · NIAAA · HARVARD MEDICAL SCHOOL · PI MILLER, GREGORY MICHAEL · 2007 to 2009
$556k
Methamphetamine Effects via Trace Amine Associated Receptor 1R21DA022323 · NIDA · HARVARD MEDICAL SCHOOL · PI MILLER, GREGORY MICHAEL · 2007 to 2009
$484k
Neurogenetics of serotonin regulation: building naturalistic rhesus monkey modelsR21MH077995 · NIMH · HARVARD MEDICAL SCHOOL · PI MILLER, GREGORY MICHAEL · 2008 to 2009
$429k
TAAR1 polymorphisms in rhesus monkeysR03DA025802 · NIDA · HARVARD MEDICAL SCHOOL · PI MILLER, GREGORY MICHAEL · 2009 to 2010
$174k
Modeling the Neurogenetics of Serotonin RegulationF32MH082507 · NIMH · HARVARD MEDICAL SCHOOL · PI VALLENDER, ERIC J. · 2007 to 2008
$93k
NCRR NIH HHS RR00168NIAAA NIH HHS AA016194NIDA NIH HHS DA016606NIDA NIH HHS DA022323NIDA NIH HHS DA025697NIDA NIH HHS DA025802NIDA NIH HHS K02 DA025697NIMH NIH HHS MH077995NIMH NIH HHS MH082507
6 · The paper itself

Abstract

backgroundThe trace amine associated receptor family is a diverse array of GPCRs that arose before the first vertebrates walked on land. Trace amine associated receptor 1 (TAAR1) is a wide spectrum aminergic receptor that acts as a modulator in brain monoaminergic systems. Other trace amine associated receptors appear to relate to environmental perception and show a birth-and-death pattern in mammals similar to olfactory receptors.

resultsAcross mammals, avians, and amphibians, the TAAR1 gene is intact and appears to be under strong purifying selection based on rates of amino acid fixation compared to neutral mutations. We have found that in dogs it has become a pseudogene. Our analyses using a comparative genetics approach revealed that the pseudogenization event predated the emergence of the Canini tribe rather than being coincident with canine domestication. By assessing the effects of the TAAR1 agonist beta-phenylethylamine on [3H]dopamine uptake in canine striatal synaptosomes and comparing the degree and pattern of uptake inhibition to that seen in other mammals, including TAAR1 knockout mice, wild type mice and rhesus monkey, we found that the TAAR1 pseudogenization event resulted in an uncompensated loss of function.

conclusionThe gene family has seen expansions among certain mammals, notably rodents, and reductions in others, including primates. By placing the trace amine associated receptors in an evolutionary context we can better understand their function and their potential associations with behavior and neurological disease.

Indexed as

Evolution, MolecularPseudogenesAnimalsDogsGene DuplicationHumansMammalsReceptors, G-Protein-CoupledTrace Amine-Associated ReceptorsReceptors, G-Protein-CoupledTrace Amine-Associated Receptors

Identifiers

PMID20167089
PMCPMC2838891
OpenAlexW2126488481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.